These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
346 related articles for article (PubMed ID: 25596135)
1. In vitro study of the neuropathic potential of the organophosphorus compounds trichlorfon and acephate. Fernandes LS; Emerick GL; dos Santos NA; de Paula ES; Barbosa F; dos Santos AC Toxicol In Vitro; 2015 Apr; 29(3):522-8. PubMed ID: 25596135 [TBL] [Abstract][Full Text] [Related]
2. In vitro study of the neuropathic potential of the organophosphorus compounds fenamiphos and profenofos: Comparison with mipafox and paraoxon. Emerick GL; Fernandes LS; de Paula ES; Barbosa F; dos Santos NA; dos Santos AC Toxicol In Vitro; 2015 Aug; 29(5):1079-87. PubMed ID: 25910916 [TBL] [Abstract][Full Text] [Related]
3. High concentration of trichlorfon (1mM) disrupts axonal cytoskeleton and decreases the expression of plasticity-related proteins in SH-SY5Y cells. Fernandes LS; Emerick GL; Ferreira RS; Santos NAGD; Santos ACD Toxicol In Vitro; 2017 Mar; 39():84-92. PubMed ID: 27939611 [TBL] [Abstract][Full Text] [Related]
4. Acetylcholinesterase and neuropathy target esterase inhibitions in neuroblastoma cells to distinguish organophosphorus compounds causing acute and delayed neurotoxicity. Ehrich M; Correll L; Veronesi B Fundam Appl Toxicol; 1997 Jul; 38(1):55-63. PubMed ID: 9268605 [TBL] [Abstract][Full Text] [Related]
5. Acetylcholinesterase and neuropathy target esterase in chickens treated with acephate. Wilson BW; Henderson JD; Kellner TP; McEuen SF; Griffis LC; Lai JC Neurotoxicology; 1990; 11(3):483-91. PubMed ID: 2284053 [TBL] [Abstract][Full Text] [Related]
6. Degradation of organophosphorus neurotoxicity in SY5Y neuroblastoma cells by organophosphorus hydrolase (OPH). Cho TM; Wild JR; Donnelly KC; Tiffany-Castiglioni E J Toxicol Environ Health A; 2006 Aug; 69(15):1413-29. PubMed ID: 16766477 [TBL] [Abstract][Full Text] [Related]
7. Neuropathy target esterase inhibition by organophosphorus esters in human neuroblastoma cells. Ehrich M; Correll L; Veronesi B Neurotoxicology; 1994; 15(2):309-13. PubMed ID: 7991219 [TBL] [Abstract][Full Text] [Related]
8. Neuropathy target esterase in mouse whole blood as a biomarker of exposure to neuropathic organophosphorus compounds. Makhaeva GF; Rudakova EV; Sigolaeva LV; Kurochkin IN; Richardson RJ J Appl Toxicol; 2016 Nov; 36(11):1468-75. PubMed ID: 26970094 [TBL] [Abstract][Full Text] [Related]
9. QSAR for the organophosphate-induced inhibition and 'aging' of the enzyme neuropathy target esterase (NTE). Singh AK SAR QSAR Environ Res; 2001; 12(3):275-95. PubMed ID: 11696925 [TBL] [Abstract][Full Text] [Related]
10. An alternative in vitro method for detecting neuropathic compounds based on acetylcholinesterase inhibition and on inhibition and aging of neuropathy target esterase (NTE). Sogorb MA; González-González I; Pamies D; Vilanova E Toxicol In Vitro; 2010 Apr; 24(3):942-52. PubMed ID: 20097283 [TBL] [Abstract][Full Text] [Related]
11. Discrimination of carboxylesterases of chicken neural tissue by inhibition with a neuropathic, non-neuropathic organophosphorus compounds and neuropathy promoter. Céspedes MV; Escudero MA; Barril J; Sogorb MA; Vicedo JL; Vilanova E Chem Biol Interact; 1997 Oct; 106(3):191-200. PubMed ID: 9413546 [TBL] [Abstract][Full Text] [Related]
12. Neurotoxicity induced in differentiated SK-N-SH-SY5Y human neuroblastoma cells by organophosphorus compounds. Hong MS; Hong SJ; Barhoumi R; Burghardt RC; Donnelly KC; Wild JR; Venkatraj V; Tiffany-Castiglioni E Toxicol Appl Pharmacol; 2003 Jan; 186(2):110-8. PubMed ID: 12639502 [TBL] [Abstract][Full Text] [Related]
13. Biochemical and clinical tests of the delayed neuropathic potential of some O-alkyl O-dichlorophenyl phosphoramidate analogues of methamidophos (O,S-dimethyl phosphorothioamidate). Johnson MK; Vilanova E; Read DJ Toxicology; 1989 Jan; 54(1):89-100. PubMed ID: 2536970 [TBL] [Abstract][Full Text] [Related]
14. Mechanisms for consideration for intervention in the development of organophosphorus-induced delayed neuropathy. Emerick GL; DeOliveira GH; dos Santos AC; Ehrich M Chem Biol Interact; 2012 Sep; 199(3):177-84. PubMed ID: 22819951 [TBL] [Abstract][Full Text] [Related]
15. Further studies toward a mouse model for biochemical assessment of neuropathic potential of organophosphorus compounds. Makhaeva GF; Rudakova EV; Hein ND; Serebryakova OG; Kovaleva NV; Boltneva NP; Fink JK; Richardson RJ J Appl Toxicol; 2014 Dec; 34(12):1426-35. PubMed ID: 24395470 [TBL] [Abstract][Full Text] [Related]
16. Relative inhibitory potencies of chlorpyrifos oxon, chlorpyrifos methyl oxon, and mipafox for acetylcholinesterase versus neuropathy target esterase. Kropp TJ; Richardson RJ J Toxicol Environ Health A; 2003 Jun; 66(12):1145-57. PubMed ID: 12791540 [TBL] [Abstract][Full Text] [Related]
17. The role of neurotoxic esterase (NTE) in the prevention and potentiation of organophosphorus-induced delayed neurotoxicity (OPIDN). Pope CN; Tanaka D; Padilla S Chem Biol Interact; 1993 Jun; 87(1-3):395-406. PubMed ID: 8343996 [TBL] [Abstract][Full Text] [Related]
19. Interactions between neuropathy target esterase and its inhibitors and the development of polyneuropathy. Lotti M; Moretto A; Capodicasa E; Bertolazzi M; Peraica M; Scapellato ML Toxicol Appl Pharmacol; 1993 Oct; 122(2):165-71. PubMed ID: 8211998 [TBL] [Abstract][Full Text] [Related]
20. Comparative in vitro study of the inhibition of human and hen esterases by methamidophos enantiomers. Emerick GL; DeOliveira GH; Oliveira RV; Ehrich M Toxicology; 2012 Feb; 292(2-3):145-50. PubMed ID: 22198100 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]